Serial Number 79356069
Registration 7301535
700

Registration Progress

Application Filed
Jul 29, 2022
Under Examination
Approved for Publication
Nov 28, 2023
Published for Opposition
Nov 28, 2023
Registered
Feb 13, 2024

Trademark Image

Basic Information

Serial Number
79356069
Registration Number
7301535
Filing Date
July 29, 2022
Registration Date
February 13, 2024
Published for Opposition
November 28, 2023
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 13, 2024
Registration
Registered
Classes
042

Rights Holder

Biotype GmbH

27
Address
Moritzburger Weg 67
01109 Dresden
DE

Ownership History

Biotype GmbH

Original Applicant
27
DE

Biotype GmbH

Owner at Publication
27
DE

Biotype GmbH

Original Registrant
27
DE

Legal Representation

Attorney
Robert S. Broder

USPTO Deadlines

Next Deadline
1482 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20240213)
Due Date
February 13, 2030
Grace Period Ends
August 13, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description Documents
Jun 11, 2024 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
May 16, 2024 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
May 16, 2024 FIMP P FINAL DISPOSITION PROCESSED Loading...
May 13, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Apr 21, 2024 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Feb 13, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Feb 13, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 28, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 28, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 27, 2023 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Nov 8, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Nov 8, 2023 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Nov 8, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 26, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 26, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Oct 26, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Oct 26, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Oct 26, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Oct 19, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 19, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 19, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 26, 2023 RFNT P REFUSAL PROCESSED BY IB Loading...
Jul 5, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jul 5, 2023 RFRR P REFUSAL PROCESSED BY MPU Loading...
May 23, 2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
May 22, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 17, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 29, 2022 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Nov 25, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 24, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 042
Scientific and technological services, namely, scientific laboratory services; science and technology services, namely, scientific research, tests and analyses for others in the field of amplification, labeling and analysis of biopolymers and nucleic acids; science and technology services, namely, contract scientific research services in the field of molecular science; services of a chemical and biochemical laboratory, namely, scientific laboratory services; design and development of measuring and testing chemical production methods in the field of molecular diagnostics; design and development of quality control measuring and testing standards in the field of oncology; design and development of blood analysis measuring and testing methods in the field of pathology; design and development of quality control measuring and testing standards in the field of microbiology; research and development of new products for others; design and testing for new product development; design and development of new technology for others in the nature of software; design and development of diagnostic laboratory devices and instruments; design and development of medical diagnostic apparatus; preparations of scientific reports being providing scientific research information; creating and further developing programs being design and development of software programs for data processing; scientific testing services in the field of molecular diagnostics; scientific testing services in the field of molecular biology; carrying out molecular biological, biochemical and immunological analyses being chemical analysis services; natural science services, namely, consultation in the field of molecular biology; technological and advisory services relating to science, namely, scientific research consulting; scientific research and development in the field of biochemistry, gene expression systems and immunology; scientific research and development in the field of diagnostic preparations; scientific research and development in the field of pharmacy, biotechnology, of microorganisms and cells; product testing, authentication of data in the field of diagnostics and quality control for others; testing, authentication and quality control, namely, computer-truncated diagnostic test services being testing of computer diagnostic software; testing, authentication and quality control, namely, computer-supported diagnostic product quality test services; quality control for others; IT services, namely, website hosting services, software as a service (SAAS) services featuring software for analyzing and reporting scientific findings, and rental of computer operating software; platform as a service (PAAS) featuring computer software platforms for database management; platform as a service (PAAS) featuring computer software platforms for analyzing data for molecular biological analyses

Additional Information

Design Mark
The mark consists of two columns of five shaded rectangles. The shaded rectangles on the left are in black. The shaded rectangles on the right are from top two bottom, two in dark grey, two in grey, and one in light grey. The color white in the mark is background only and not claimed as a feature of the mark.
Color Claim
The color(s) grey, black, dark grey and light grey is/are claimed as a feature of the mark.

Classification

International Classes
042